126 related articles for article (PubMed ID: 19776486)
1. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2009; 33(3 Suppl 2):41-56. PubMed ID: 19776486
[TBL] [Abstract][Full Text] [Related]
2. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2007; 31(2-3 Suppl 2):33-47. PubMed ID: 17824361
[TBL] [Abstract][Full Text] [Related]
3. [Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity].
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2012; 36(6 Suppl 1):39-54. PubMed ID: 23293270
[TBL] [Abstract][Full Text] [Related]
4. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2008 activity.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2010; 34(5-6 Suppl 4):35-51. PubMed ID: 21220836
[TBL] [Abstract][Full Text] [Related]
5. Extension of organized cervical cancer screening programmes in Italy and their process indicators, 2011-2012 activity.
Ronco G; Giubilato P; Carozzi F; Maia G; Giorgi Rossi P; Zappa M;
Epidemiol Prev; 2015; 39(3 Suppl 1):61-76. PubMed ID: 26405778
[TBL] [Abstract][Full Text] [Related]
6. Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2009 activity.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2011; 35(5-6 Suppl 5):39-54. PubMed ID: 22166349
[TBL] [Abstract][Full Text] [Related]
7. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2008; 32(2 Suppl 1):37-54. PubMed ID: 18770994
[TBL] [Abstract][Full Text] [Related]
8. Activity level and process indicators of organised programmes for cervical cancer screening in Italy.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2006; 30(1 Suppl 3):27-40. PubMed ID: 16937844
[TBL] [Abstract][Full Text] [Related]
9. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
10. A first survey of HPV-based screening in routine cervical cancer screening in Italy.
Ronco G; Giorgi Rossi P; Giubilato P; Del Mistro A; Zappa M; Carozzi F;
Epidemiol Prev; 2015; 39(3 Suppl 1):77-83. PubMed ID: 26405779
[TBL] [Abstract][Full Text] [Related]
11. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
12. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
[TBL] [Abstract][Full Text] [Related]
13. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes.
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2007; 31(2-3 Suppl 2):61-8. PubMed ID: 17824363
[TBL] [Abstract][Full Text] [Related]
14. Performance indicators of organized cervical screening in Romagna (Italy).
Bucchi L; Falcini F; Schincaglia P; Desiderio F; Bondi A; Farneti M; Casadei Giunchi D; Serafini M; Canuti D; Caprara L; Sabbadini F; Monari F; Sassoli P
Eur J Cancer Prev; 2003 Jun; 12(3):223-8. PubMed ID: 12771561
[TBL] [Abstract][Full Text] [Related]
15. A comparison of diagnostic indicators of cervical cancer screening among women accessing through volunteer organisations and those via the organised programme in Turin (Piedmont Region, Northern Italy).
Ferrante G; Castagno R; Rizzolo R; Armaroli P; Caprioglio A; Larato C; Giordano L
Epidemiol Prev; 2020; 44(5-6 Suppl 1):115-123. PubMed ID: 33415954
[TBL] [Abstract][Full Text] [Related]
16. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; Minucci D; Naldoni C; Rizzolo R; Schincaglia P; Volante R; Zappa M; Zorzi M; Cuzick J; Segnan N;
J Natl Cancer Inst; 2008 Apr; 100(7):492-501. PubMed ID: 18364502
[TBL] [Abstract][Full Text] [Related]
17. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
[TBL] [Abstract][Full Text] [Related]
18. Cervical human papilloma virus (HPV) DNA primary screening test: Results of a population-based screening programme in central Italy.
Passamonti B; Gustinucci D; Giorgi Rossi P; Cesarini E; Bulletti S; Carlani A; Martinelli N; Broccolini M; D'Angelo V; D'Amico MR; Di Dato E; Galeazzi P; Malaspina M; Spita N; Tintori B; Giaimo MD
J Med Screen; 2017 Sep; 24(3):153-162. PubMed ID: 27614992
[TBL] [Abstract][Full Text] [Related]
19. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
20. Quality of colposcopy and treatment--data from the national survey of Italian organised cervical screening programmes: 2006 activity.
Volante R; Giubilato P; Ronco G
Epidemiol Prev; 2009; 33(3 Suppl 2):75-82. PubMed ID: 19776488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
